Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)

China flag China · Delayed Price · Currency is CNY
36.00
+0.25 (0.70%)
At close: Dec 5, 2025
16.96%
Market Cap33.13B
Revenue (ttm)2.48B
Net Income (ttm)-949.86M
Shares Outn/a
EPS (ttm)-0.96
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,356,253
Average Volume6,185,364
Open35.75
Previous Close35.75
Day's Range35.19 - 36.05
52-Week Range24.72 - 51.40
Beta0.91
RSI39.04
Earnings DateMar 26, 2026

About SHA:688180

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 2,578
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688180
Full Company Profile

Financial Performance

In 2024, SHA:688180's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.

Financial Statements

News

There is no news available yet.